Phase II study of nab-paclitaxel and carboplatin for elderly patients with non-small cell lung cancer. (KRSG1303)
Phase 2
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000011534
- Lead Sponsor
- Kanto respiratory disease study group
- Brief Summary
This trial stopped because the targeted number of cases cannot be achieved.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with Symptomatic brain metastasis 2) Patients have only non-measurable lesion 3) Patients with radiotherapy for cancer within 4 weeks 4) Patients with interstitial pneumonia 5) Patients with Serious complications (renal dysfunction, liver dysfunction, cardiac diseases, uncontrolled hypertension or diabetes) 6) Patients with other Serious complications 7) Judged ineligible based on physicians' decision
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Disease control rate, Frequent of adverse event, Progression free survival, Overall Survival, Rate of secondary treatment